L Trampert

Imaging-based target volume reduction in chemoradiotherapy for locally advanced non-small-cell lung cancer (PET-Plan): a multicentre, open-label, randomised, controlled trial

Ursula Nestle, Tanja Schimek‐Jasch, Stephanie Kremp et al. · The Lancet Oncology · 2020 · 169 citations

Engineering, Oncologic Imaging, Medical Imaging +9

Investigations of breast tumors with fluorine-18-fluorodeoxyglucose and SPECT.

L.-H. Holle, L Trampert, S. Lung-Kurt et al. · PubMed · 1996 · 28 citations

PSA and PSA Kinetics Thresholds for the Presence of 68Ga-PSMA-11 PET/CT-Detectable Lesions in Patients with Biochemical Recurrent Prostate Cancer

Manuela A. Hoffmann, Hans‐Georg Buchholz, Helmut J. Wieler et al. · Cancers · 2020 · 25 citations · Full text

The positivity rate of 68Gallium-PSMA-11 ligand PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer

Manuela A. Hoffmann, Hans‐Georg Buchholz, Helmut J. Wieler et al. · Oncotarget · 2019 · 20 citations · Full text

Radioimmunoscintigraphy of ovarian tumours with technetium-99m labelled monoclonal antibody-170: first clinical experiences

Christof Alexander, C Villena-Heinsen, L Trampert et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1995 · 19 citations

Oncologic Imaging, Medicine, First Clinical Experiences +8